Annals of clinical and translational neurology · 2026
Natural Frequencies of Levodopa-Induced Dyskinesia in Parkinson's Disease.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Isaias Ioannis U, Avantaggiato Federica, Pezzoli Gianni, Canessa Andrea
Аннотация
OBJECTIVES: Abnormal involuntary movements, known as dyskinesias, are common complications of levodopa treatment in patients with Parkinson's disease and can significantly impair quality of life. The underlying pathophysiology remains unclear, and current therapeutic options are limited. This study aimed to investigate the oscillatory dynamics of the supplementary motor area during levodopa administration and the emergence of dyskinesias.
METHODS: We applied transcranial magnetic stimulation to directly perturb the supplementary motor area and used high-density electroencephalography to measure its natural oscillatory frequency during levodopa administration and the emergence of dyskinesias.
RESULTS: Levodopa intake increased cortical excitability in both dyskinetic and non-dyskinetic parkinsonian patients. Transcranial magnetic stimulation consistently evoked dominant beta-gamma oscillations in both groups. Notably, dyskinetic patients exhibited a shift of event-related spectral perturbation toward beta low frequencies, paralleling the clinical manifestation of peak-of-dose dyskinesias.
INTERPRETATION: These findings support the view of dyskinesias as disorders of oscillatory local and network activity and suggest that targeted neuromodulation strategies could be developed to mitigate these motor complications.
METHODS: We applied transcranial magnetic stimulation to directly perturb the supplementary motor area and used high-density electroencephalography to measure its natural oscillatory frequency during levodopa administration and the emergence of dyskinesias.
RESULTS: Levodopa intake increased cortical excitability in both dyskinetic and non-dyskinetic parkinsonian patients. Transcranial magnetic stimulation consistently evoked dominant beta-gamma oscillations in both groups. Notably, dyskinetic patients exhibited a shift of event-related spectral perturbation toward beta low frequencies, paralleling the clinical manifestation of peak-of-dose dyskinesias.
INTERPRETATION: These findings support the view of dyskinesias as disorders of oscillatory local and network activity and suggest that targeted neuromodulation strategies could be developed to mitigate these motor complications.